Shelf life (days): 1460.0
Formulation: A solid
Formal Name: [3R-(3a,5aß,6ß,8aß,9a,12ß,12aR*)]-octahydro-3,6-dimethyl-9-(methyl-d3)-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
Purity: ≥99% deuterated forms (d1-d3)
Formula Markup: C15H19D3O5
Formula Weight: 285.35036
CAS Number: 176652-07-6
Notes: Artemisinin-d3 is intended for use as an internal standard for the quantification of artemisinin (Item No. 11816). Artemisinin is an endoperoxide antimalarial agent with anticancer activity.{21232,37702} It reduces the growth of various P. falciparum strains in vitro (IC50s = 3.98-20.36 nM) and reduces parasitemia in mice infected with P. falciparum with a curative dose (CD50) value of 140 mg/kg.{21232,37703} It also reduces P. berghei infection in mice (ED50 = 5.6 mg/kg per day).{37704} Artemisinin (100-400 μM) induces cell cycle arrest in the G0/G1 phase and apoptosis and inhibits growth of SK-N-AS, BE(2)-C, SK-N-DZ, and SHEP1 neuroblastoma cells in a time- and concentration-dependent manner.{37702} It also suppresses BE(2)-C cell colony formation in a soft agar assay and reduces tumor growth in a BE(2)-C mouse xenograft model. Formulations containing artemisinin have been used in combination therapies for the treatment of malaria.
Deutsch
English
